Last Updated: September 6, 2026

Patent: 10,588,949

✉ Email this page to a colleague

Summary for Patent: 10,588,949

Title:	Factor IX polypeptide formulations
Abstract:	The present invention provides formulations comprising a Factor IX-FcRn Binding Partner (FIXFBP) polypeptide, and methods of administering FIXFBP.
Inventor(s):	Mark Brader
Assignee:	Bioverativ Therapeutics Inc , Biogen MA Inc
Application Number:	US14/776,125
Patent Claims:	see list of patent claims

Details for Patent 10,588,949

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Bioverativ Therapeutics, Inc.	ALPROLIX	coagulation factor ix (recombinant), fc fusion protein	For Injection	125444	28-Mar-14	⤷ Start Trial	2034-03-14
Bioverativ Therapeutics, Inc.	ALPROLIX	coagulation factor ix (recombinant), fc fusion protein	For Injection	125444	18-Feb-16	⤷ Start Trial	2034-03-14
Bioverativ Therapeutics, Inc.	ALPROLIX	coagulation factor ix (recombinant), fc fusion protein	For Injection	125444	14-Jul-16	⤷ Start Trial	2034-03-14
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,588,949

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Argentina	095527	⤷ Start Trial
Australia	2014228938	⤷ Start Trial
Australia	2019202348	⤷ Start Trial
Australia	2019208273	⤷ Start Trial
Australia	2022228110	⤷ Start Trial
Canada	2899089	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.